Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12857 | 814 | 31.6 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
597 | 13382 | HEPATOCELLULAR CARCINOMA//HEPATOBLASTOMA//GLYPICAN 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DES GAMMA CARBOXY PROTHROMBIN | Author keyword | 63 | 67% | 7% | 56 |
2 | GOLGI PROTEIN 73 | Author keyword | 51 | 91% | 3% | 21 |
3 | GP73 | Author keyword | 24 | 82% | 2% | 14 |
4 | AFP L3 | Author keyword | 23 | 69% | 2% | 20 |
5 | DES GAMMA CARBOXYPROTHROMBIN | Author keyword | 23 | 72% | 2% | 18 |
6 | ALPHA FETOPROTEIN | Author keyword | 19 | 10% | 21% | 173 |
7 | PIVKA II | Author keyword | 19 | 43% | 4% | 34 |
8 | FUCOSYLATION INDEX | Author keyword | 15 | 88% | 1% | 7 |
9 | DES GAMMA CARBOXY PROTHROMBIN DCP | Author keyword | 13 | 80% | 1% | 8 |
10 | GOLPH2 | Author keyword | 12 | 75% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DES GAMMA CARBOXY PROTHROMBIN | 63 | 67% | 7% | 56 | Search DES+GAMMA+CARBOXY+PROTHROMBIN | Search DES+GAMMA+CARBOXY+PROTHROMBIN |
2 | GOLGI PROTEIN 73 | 51 | 91% | 3% | 21 | Search GOLGI+PROTEIN+73 | Search GOLGI+PROTEIN+73 |
3 | GP73 | 24 | 82% | 2% | 14 | Search GP73 | Search GP73 |
4 | AFP L3 | 23 | 69% | 2% | 20 | Search AFP+L3 | Search AFP+L3 |
5 | DES GAMMA CARBOXYPROTHROMBIN | 23 | 72% | 2% | 18 | Search DES+GAMMA+CARBOXYPROTHROMBIN | Search DES+GAMMA+CARBOXYPROTHROMBIN |
6 | ALPHA FETOPROTEIN | 19 | 10% | 21% | 173 | Search ALPHA+FETOPROTEIN | Search ALPHA+FETOPROTEIN |
7 | PIVKA II | 19 | 43% | 4% | 34 | Search PIVKA+II | Search PIVKA+II |
8 | FUCOSYLATION INDEX | 15 | 88% | 1% | 7 | Search FUCOSYLATION+INDEX | Search FUCOSYLATION+INDEX |
9 | DES GAMMA CARBOXY PROTHROMBIN DCP | 13 | 80% | 1% | 8 | Search DES+GAMMA+CARBOXY+PROTHROMBIN+DCP | Search DES+GAMMA+CARBOXY+PROTHROMBIN+DCP |
10 | GOLPH2 | 12 | 75% | 1% | 9 | Search GOLPH2 | Search GOLPH2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARBOXYPROTHROMBIN | 142 | 96% | 6% | 45 |
2 | ABNORMAL PROTHROMBIN | 137 | 70% | 14% | 114 |
3 | VITAMIN K ABSENCE | 85 | 85% | 6% | 45 |
4 | GAMMA CARBOXY PROTHROMBIN | 70 | 42% | 16% | 130 |
5 | GP73 | 59 | 84% | 4% | 32 |
6 | ANTAGONIST II | 32 | 85% | 2% | 17 |
7 | IMMUNOREACTIVE PROTHROMBIN | 30 | 100% | 1% | 12 |
8 | LECTIN AFFINITY ELECTROPHORESIS | 29 | 63% | 4% | 30 |
9 | CARBOXY PROTHROMBIN | 29 | 77% | 2% | 20 |
10 | REACTIVE ALPHA FETOPROTEIN | 27 | 49% | 5% | 39 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-gamma-carboxyprothrombin | 2011 | 22 | 97 | 71% |
Hepatocellualar Carcinoma Serum Markers | 2012 | 50 | 180 | 28% |
New Serum Markers of Hepatocellular Carcinoma | 2012 | 26 | 51 | 41% |
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications | 2008 | 61 | 96 | 53% |
Alpha-fetoprotein-L3 in hepatocellular carcinoma: A meta-analysis | 2013 | 4 | 49 | 82% |
Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma | 2011 | 26 | 49 | 39% |
Present and future possibilities for early diagnosis of hepatocellular carcinoma | 2010 | 62 | 60 | 42% |
Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis | 2013 | 10 | 10 | 40% |
Serum tumor markers for detection of hepatocellular carcinoma | 2006 | 123 | 67 | 33% |
Serum markers of hepatocellular carcinoma | 2006 | 52 | 59 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OSAKA S | 4 | 33% | 1.4% | 11 |
2 | EVALUAT FOOD DRUG | 2 | 67% | 0.2% | 2 |
3 | FOOD NUTR SCI BIOCHEM | 2 | 67% | 0.2% | 2 |
4 | NEW DIAGNOST BUSINESS TECHNOL DEV | 2 | 50% | 0.4% | 3 |
5 | CELLULAR FUNCT GASTROENTEROL HEPATOL | 1 | 50% | 0.2% | 2 |
6 | CENT CLIN HEPATOL | 1 | 100% | 0.2% | 2 |
7 | FUKUSHIMA IND UNIV GOVT | 1 | 100% | 0.2% | 2 |
8 | MT VIEW RD | 1 | 100% | 0.2% | 2 |
9 | CLIN MED INFORMAT | 1 | 40% | 0.2% | 2 |
10 | BIOBANK GRP | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176831 | ALPHA FETOPROTEIN//ALPHA FETOPROTEIN RECEPTOR//RECAF |
2 | 0.0000160199 | HEPATOID ADENOCARCINOMA//HEPATOID CARCINOMA//HEPATOID |
3 | 0.0000152493 | HEPATOCELLULAR CARCINOMA//TRANSARTERIAL CHEMOEMBOLIZATION//MIRIPLATIN |
4 | 0.0000150374 | HCCR 1//HUMAN CERVICAL CANCER ONCOGENE//HCCR |
5 | 0.0000144779 | GLYPICAN 3//GPC3//SIMPSON GOLABI BEHMEL SYNDROME |
6 | 0.0000131073 | DEVELOPING COMMUNITY//ALPHAFOETOPROTEIN//19 |
7 | 0.0000086423 | FUCOSIDOSIS//ALPHA L FUCOSIDASE//FUCOSE DEHYDROGENASE |
8 | 0.0000080584 | MATERNAL SERUM ALPHA FETOPROTEIN//MATERNAL SERUM ALPHA FETOPROTEIN MSAFP//MATERNAL SERUM HUMAN CHORIONIC GONADOTROPIN |
9 | 0.0000079947 | MILAN CRITERIA//UCSF CRITERIA//SALVAGE LIVER TRANSPLANTATION |
10 | 0.0000074817 | CALUMENIN//BIOCHEM FUNCT PROTE//RETICULOCALBIN |